HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Sublobar curative resection for non-small-cell lung cancer].

Abstract
It has been proved that lobectomy for lung cancer of less than 3 cm is superior to sublobar resection (segmentectomy and wedge resection) in the Lung Cancer Study Group trial published in 1995. Lobectomy is therefore recommended, with lymph node resection. Nevertheless, some publications have shown identical or close results after segmentectomy for tumors of less than 2 cm, and after wedge resection for tumors of less than 1 cm. It is likely that local recurrences are avoided by respecting a macroscopic margin of more than 2 cm around the tumor. A new trial comparing lobectomy and sublobar resection has been ongoing since 2007 for tumors of less than 2 cm. Persistent ground glass opacities are now often discovered after screening, either pure or with a small solid component, and correspond to an in situ or a micro-invasive adenocarcinoma, that can be removed with sublobar resection without recurrence.
AuthorsPierre Bonnette
JournalBulletin du cancer (Bull Cancer) Vol. 99 Issue 11 Pg. 1069-75 (Nov 2012) ISSN: 1769-6917 [Electronic] France
Vernacular TitleRésections carcinologiques limitées des cancers non à petites cellules du poumon.
PMID23092959 (Publication Type: Journal Article, Review)
Topics
  • Carcinoma, Non-Small-Cell Lung (diagnostic imaging, pathology, secondary, surgery)
  • Humans
  • Lung (surgery)
  • Lung Neoplasms (diagnostic imaging, pathology, surgery)
  • Lymph Node Excision
  • Neoplasm Recurrence, Local (prevention & control)
  • Pneumonectomy (methods, standards)
  • Practice Guidelines as Topic
  • Radiography
  • Tumor Burden

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: